About   |  Speaker   |  Programme   |  Registration   |  Sponsoring

 


Biologics and Biosimilars -

Challenges in Implementation and Adoption

 

Novel therapeutic approaches in Regenerative Medicine aiming to replace or regenerate diseased tissue have vast potential to tackle unmet patient needs. 

Digital health trends show that a big change has been observed to be shaping up especially in the last year, particularly after so many years of small but progressive steps taken towards digital “evolution”. Health and biomedical data are also contributing towards the big data explosion and therefore has the power to transform medicine. [1] 

It should be interesting to explore the value of the advancements that digital health brings with regards to improving consumer experience, care delivery methods as well as the new career development opportunities that it introduces into the healthcare industry, as big data can drive us towards better health and growth in economy as outlined in Lord Howe’s (the Parliamentary under Secretary of State at the Department of Health) vision, showing government’s commitment towards a strong commercial life sciences industry. Also it will be interesting to explore how the big data is affecting pharmaceutical research. [2]

WHAT ARE THE WAYS IN WHICH BIG DATA CAN AFFECT PHARMACEUTICAL RESEARCH?

WHAT ARE SOME OF THE WAYS IN, WHICH DIGITAL HEALTHCARE CAN BRING ECONOMIC GROWTH TO THE UK?

ON A PERSONAL LEVEL, INDIVIDUALS WOULD BE INTERESTED IN FINDING MORE ABOUT LATEST STRATEGIES AND ADVANCEMENTS IN DIGITAL HEALTHCARE TO MANAGE AND TO PROVIDE PERSON CENTRED AND QUALITY CARE TO PATIENTS.


Speakers

 


Programme

 


Registration

 


Sponsoring